Elevated uric acid is more than a marker for gout. Growing evidence suggests it reflects metabolic inflammation and oxidative stress linked to increased colorectal cancer risk. This physician-led review explores how uric acid functions as a predictive biomarker, its relationship to insulin resistance and chronic inflammation, and how average-risk screening tools like Cologuard fit into a modern preventive care strategy focused on early detection and risk reduction.